Blanca Boluda

11PUBLICATIONS
73CO-AUTHORS
Haematological tumoursCardiovascular medicine and haematology not elsewhere classifiedNanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 11, 2026
Gain and Loss of FLT3 Mutations in Patients with Acute Myeloid Leukemia: A Noninterventional Cohort Study (CLEVO).

Cristina Papayannidis, Irina Amitai, Pascal Turlure

|Sep 13, 2025
Healthcare Resource Utilization and Treatment Costs for Blastic Plasmacytoid Dendritic Cell Neoplasm: A PETHEMA Study.

Antonio Solana-Altabella, Irene Navarro-Vicente, Eduardo Rodríguez-Arbolí

|Aug 30, 2025
Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia.

Antonio Solana-Altabella, Carles Iniesta-Navalón, Maria Chovi-Trull

|Sep 02, 2022
No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group.

Tamara Castaño-Bonilla, Eva Barragán, Claudia Sargas

|Jun 10, 2022
Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia.

David Martínez-Cuadrón, Josefina Serrano, José Mariz

|Apr 23, 2022
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study.

Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López

Pageof 2

Frequent Collaborators

8 joint publications

David Martínez-Cuadrón

8 joint publications

Pau Montesinos

6 joint publications

MiguelÁngel Sanz

6 joint publications

Antonio Solana-Altabella